Author:
Stüve Olaf,Greenberg Benjamin M
Reference11 articles.
1. Multiple sclerosis—the plaque and its pathogenesis;Frohman;N Engl J Med,2006
2. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS;van der Valk;Neuropathol Appl Neurobiol,2000
3. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta;Wynn;Lancet Neurol,2010
4. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis;Bielekova;Proc Natl Acad Sci USA,2006
5. Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets;Timonen;Cell Immunol,1979
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献